{"id":"https://openalex.org/W4220962467","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p2-13-02","title":"Abstract P2-13-02: Pathologic nodal staging and systemic therapy among patients with cT1-2N0 HER2+ breast cancer: A prospective single institution cohort analysis","display_name":"Abstract P2-13-02: Pathologic nodal staging and systemic therapy among patients with cT1-2N0 HER2+ breast cancer: A prospective single institution cohort analysis","publication_year":2022,"publication_date":"2022-02-15","ids":{"openalex":"https://openalex.org/W4220962467","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p2-13-02"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs21-p2-13-02","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p2-13-02","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs21-p2-13-02","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012303632","display_name":"Anna Catherine Weiss","orcid":"https://orcid.org/0000-0001-5671-959X","observed_orcids":["https://orcid.org/0000-0001-5671-959X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Weiss","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089866079","display_name":"Adrienne Gropper Waks","orcid":"https://orcid.org/0000-0001-5649-7229","observed_orcids":["https://orcid.org/0000-0001-5649-7229"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrienne G. Waks","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020313654","display_name":"Alison Laws","orcid":"https://orcid.org/0000-0002-9933-6705","observed_orcids":["https://orcid.org/0000-0002-9933-6705"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alison Laws","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069056507","display_name":"Sara M. Tolaney","orcid":"https://orcid.org/0000-0002-5940-8671","observed_orcids":["https://orcid.org/0000-0002-5940-8671"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara M. Tolaney","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070245248","display_name":"Eric P. Winer","orcid":"https://orcid.org/0000-0002-8819-1723","observed_orcids":["https://orcid.org/0000-0002-8819-1723"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric P. Winer","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029062544","display_name":"Elizabeth Ann Mittendorf","orcid":"https://orcid.org/0000-0002-9762-8536","observed_orcids":["https://orcid.org/0000-0002-9762-8536"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Mittendorf","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039694693","display_name":"Ann H. Partridge","orcid":"https://orcid.org/0000-0002-4722-4824","observed_orcids":["https://orcid.org/0000-0002-4722-4824"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann H. Partridge","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076310424","display_name":"Tari A. King","orcid":"https://orcid.org/0000-0003-3602-2351","observed_orcids":["https://orcid.org/0000-0003-3602-2351"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tari A. King","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"4_Supplement","first_page":"P2","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.03440000116825104,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/clinically-node-negative-breast-cancer","display_name":"clinically node-negative breast cancer","score":0.7649999856948853},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8579999804496765},{"id":"https://openalex.org/keywords/upfront-surgery","display_name":"upfront surgery","score":0.9409999847412109},{"id":"https://openalex.org/keywords/isolated-tumor-cells","display_name":"isolated tumor cells","score":0.8790000081062317},{"id":"https://openalex.org/keywords/axillary-lymph-node-metastasis","display_name":"axillary lymph node metastasis","score":0.7009999752044678},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.7279999852180481},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.5699999928474426},{"id":"https://openalex.org/keywords/axillary-ultrasound","display_name":"axillary ultrasound","score":0.5199999809265137},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.652999997138977},{"id":"https://openalex.org/keywords/treatment-strategy-comparison","display_name":"treatment strategy comparison","score":0.3149999976158142},{"id":"https://openalex.org/keywords/tumor-grade","display_name":"tumor grade","score":0.3619999885559082},{"id":"https://openalex.org/keywords/age-at-diagnosis","display_name":"age at diagnosis","score":0.41999998688697815}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9344677925109863},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7288598418235779},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.5796099901199341},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5565382242202759},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49087101221084595},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.46606117486953735},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4659830927848816},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.43848907947540283},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.432546466588974},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.397968590259552}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs21-p2-13-02","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p2-13-02","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs21-p2-13-02","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4391997837","https://openalex.org/W4229040519","https://openalex.org/W2169798282","https://openalex.org/W4360600195","https://openalex.org/W4401905459","https://openalex.org/W3125588037","https://openalex.org/W3118447990","https://openalex.org/W2768918443","https://openalex.org/W4411290823","https://openalex.org/W4412684248"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"The":[2,23,236],"optimal":[3],"systemic":[4,325,503],"therapy":[5,326,504],"strategy,":[6],"neoadjuvant":[7,47],"vs":[8,187,198,207,217],"adjuvant":[9,324],"therapy,":[10],"for":[11,55,66,403,423],"patients":[12,72,162,179,247,253,278,301,396,426,506],"with":[13,43,130,153,169,175,273,279,363,367,397,507],"small":[14],"clinically":[15],"node":[16],"negative":[17,136],"HER2+":[18,40,69,358,424,509],"breast":[19,70,359,510],"cancers":[20],"is":[21],"uncertain.":[22],"goal":[24],"of":[25,33,79,114,159,238,267,292,311,355,370,392,408,521],"this":[26,352,412],"study":[27],"was":[28,64,96,106,241,260,287,330,365],"to":[29,50,343,373],"evaluate":[30],"the":[31,80,139,265,389,409,522],"incidence":[32,237],"pathologic":[34],"nodal":[35,435,500],"disease":[36,116,196,240,313,394],"in":[37,138,224,233,264,277,290,332,337,347,395,411],"cT1-2":[38,67,356],"N0":[39,68,357],"patients,":[41,258,323,361,388],"treated":[42,168],"upfront":[44,140,170,245,256,295,321,376,386,431,438],"surgery":[45,89,141,171,178,246,257,296,322,387,439],"or":[46],"chemotherapy":[48],"(NAC),":[49],"better":[51],"define":[52],"selection":[53],"criteria":[54],"initial":[56],"treatment":[57,120,362],"approach.":[58],"Methods:":[59],"Our":[60],"prospectively":[61],"maintained":[62],"database":[63],"queried":[65],"cancer":[71,360],"diagnosed":[73],"2/12/2015":[74],"-":[75],"10/13/2020":[76],"(after":[77],"publication":[78],"Adjuvant":[81],"Paclitaxel":[82],"and":[83,112,125,172,210,227,248,281,299,340,440,502],"Trastuzumab":[84],"trial).":[85],"Patients":[86],"without":[87],"axillary":[88,104,214],"were":[90,117,134,163,167,180,383],"excluded":[91],"(n":[92],"=23).":[93],"HER2":[94],"positivity":[95],"defined":[97],"per":[98],"ASCO/CAP":[99],"guidelines.":[100],"Pre-NAC":[101],"and/or":[102],"pre-operative":[103],"ultrasound":[105,215],"not":[107,308],"routinely":[108],"performed.":[109],"Patient":[110],"characteristics":[111],"rates":[113,369,382],"pN+":[115,154,239,268,312,371,393],"compared":[118,372],"by":[119],"strategy":[121],"using":[122],"Chi":[123],"square":[124],"Wilcoxon":[126],"rank-sum":[127],"tests.":[128],"Nodes":[129],"isolated":[131],"tumor":[132],"cells":[133],"considered":[135],"(pN0)":[137],"setting":[142],"but":[143],"positive":[144],"(pN+)":[145],"after":[146],"NAC.":[147,176],"Logistic":[148],"regression":[149],"determined":[150],"factors":[151],"associated":[152,366],"disease.":[155],"Results:":[156],"A":[157,512],"total":[158],"579":[160],"eligible":[161],"identified;":[164],"368":[165],"(63.6%)":[166],"211":[173],"(36.4%)":[174],"Upfront":[177],"older":[181],"(median":[182],"55":[183],"years":[184],"[range":[185],"23-88]":[186],"49":[188],"[24-79],":[189],"p<0.001);":[190,209],"less":[191,201,211],"frequently":[192,202,212],"had":[193,203],"grade":[194],"3":[195],"(58.4%":[197],"67.3%,":[199],"p=0.008);":[200],"T2":[204],"tumors":[205,283,399],"(14.4%":[206],"82.5%,":[208],"underwent":[213],"(21.2%":[216],"62.6%,":[218],"p<0.001).":[219],"NAC":[220,252,300,364,421,441],"included":[221],"multi-chemotherapy":[222,345],"regimens":[223,232,342,346,422],"46":[225],"(21.8%)":[226],"more":[228,404],"than":[229],"one":[230],"HER2-targeted":[231],"165":[234],"(78.2%).":[235],"73/368":[242],"(19.8%)":[243],"among":[244,251,437,505],"26/211":[249],"(12.3%)":[250],"(p=0.021).":[254],"Among":[255,320],"there":[259],"a":[261],"significant":[262],"difference":[263,289],"distribution":[266],"across":[269],"T":[270],"categories":[271],"(p<0.001)":[272],"an":[274,401],"increased":[275],"rate":[276,310,391],"cT1c":[280],"cT2":[282],"(Table":[284],"1).":[285],"There":[286],"no":[288],"use":[291],"ALND":[293,381],"between":[294],"(22/368":[297],"[6.0%])":[298],"(18/211":[302],"[8.5%],":[303],"p=0.173).":[304],"Hormone-receptor":[305],"status":[306],"did":[307],"impact":[309],"(OR":[314],"1.024,":[315],"95%":[316],"CI:":[317],"0.601-1.747,":[318],"p=0.929).":[319],"(excluding":[327],"endocrine":[328],"therapy)":[329],"given":[331],"269":[333],"(73.1%)":[334],"including":[335],"paclitaxel/trastuzumab":[336],"158":[338],"(42.9%)":[339],"other":[341],"include":[344],"111":[348],"(30.2%).":[349],"Conclusions:":[350],"In":[351,385],"large":[353],"cohort":[354,516],"lower":[368],"those":[374],"undergoing":[375,430],"surgery.":[377,432],"Despite":[378],"these":[379],"differences,":[380],"similar.":[384],"higher":[390],"cT1c-T2":[398],"suggests":[400],"opportunity":[402],"comprehensive":[405],"radiographic":[406],"examination":[407],"axilla":[410],"subgroup.":[413],"Further":[414],"investigation":[415],"could":[416],"also":[417],"focus":[418],"on":[419],"tailoring":[420],"cN0":[425],"who":[427],"are":[428],"presently":[429],"Table":[433],"1.Pathologic":[434],"stage":[436],"patientsUpfront":[442],"Surgery":[443],"(N=368)pN+pN0P":[444],"valuecT":[445,464],"category<":[446],"0.001T1mi":[447],"(N=48)6":[448],"(10.4%)42":[449],"(89.6%)T1a":[450],"(N=26)3":[451],"(11.5%)23":[452],"(88.5%)T1b":[453],"(N=87)7":[454],"(8.0%)80":[455],"(92.0%)T1c":[456],"(N=154)38":[457],"(24.7%)116":[458],"(75.3%)T2":[459],"(N=53)19":[460],"(35.8%)34":[461],"(64.2%)NAC":[462],"(N=211)ypN+ypN0P":[463],"category0.719T1b":[465],"(N=7)1":[466],"(14.3%)6":[467],"(85.7%)T1c":[468],"(N=30)5":[469],"(16.7%)25":[470],"(83.3%)T2":[471],"(N=174)20":[472],"(11.5%)154":[473],"(88.5%)":[474],"Citation":[475],"Format:":[476],"Anna":[477],"Weiss,":[478],"Adrienne":[479],"G.":[480],"Waks,":[481],"Alison":[482],"Laws,":[483],"Sara":[484],"M.":[485],"Tolaney,":[486],"Eric":[487],"P.":[488],"Winer,":[489],"Elizabeth":[490],"A.":[491,497],"Mittendorf,":[492],"Ann":[493],"H.":[494],"Partridge,":[495],"Tari":[496],"King.":[498],"Pathologic":[499],"staging":[501],"cT1-2N0":[508],"cancer:":[511],"prospective":[513],"single":[514],"institution":[515],"analysis":[517],"[abstract].":[518],"In:":[519],"Proceedings":[520],"2021":[523,529],"San":[524,532],"Antonio":[525],"Breast":[526],"Cancer":[527,538],"Symposium;":[528],"Dec":[530],"7-10;":[531],"Antonio,":[533],"TX.":[534],"Philadelphia":[535],"(PA):":[536],"AACR;":[537],"Res":[539],"2022;82(4":[540],"Suppl):Abstract":[541],"nr":[542],"P2-13-02.":[543]},"counts_by_year":[{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2022-04-03T00:00:00"}